Aziyo Biologics to Participate in Upcoming Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY

6. AVGO
7. SPCX
8. BJ
9. OSIS
10. HD

Get Alerts AZYO Hot Sheet

Price: $1.49 --0%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

SILVER SPRING, Md., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced that management will be participating in the following investor conferences:

34th Annual Piper Sandler Healthcare ConferenceLocation: New York, NYFormat: Fireside chat and 1x1 meetings Date: December 1, 2022Time: 11:30 a.m. ETParticipants: C. Randall Mills, Ph.D., President and Chief Executive Officer, and Matthew Ferguson, Chief Financial Officer

Cantor Medical & Aesthetic Dermatology, Ophthalmology & Medtech ConferenceLocation: Miami, FLFormat: Panel discussion entitled “R&R: Regenerative & Restoration Medicine” and 1x1 meetings Date: December 8, 2022Time: 2:45 p.m. ETParticipant: C. Randal Mills, Ph.D.

A webcast of the fireside chat at the Piper Sandler conference can be accessed by visiting https://investors.aziyo.com/events-presentations. A replay will be available on the Company's website following the event. A recording of the panel discussion at the Cantor conference will be made available only to clients of Cantor Fitzgerald.

About Aziyo BiologicsAziyo Biologics is a regenerative medicine company with a commercial portfolio of differentiated products focused on improving outcomes in patients undergoing a range of surgical procedures, primarily for implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.

Investors:Matt FergusonAziyo Biologics, Inc.[email protected]

Media:Courtney GuyerAziyo Biologics, Inc.[email protected]